Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
eNq1mE1z2jAQhu/8Co8PvWHjEIhpbTItTVpmkiklYdrpJSPsJYgKydEHkPz6ypg0pCMmVKAjlvzuenf1+MXJ+WpOvAVwgRlN/Sho+B7QjOWY3qf+6PayHvvn3VoyQwv0su1E7wuiyPcygoRI/XI1GAOiIvh5ffUZ9P3A/W7NS9h4Bpl8tU9JTIKvSEyvUVHu8ZIFw7k3BzlleeoXSq6veomQXGfRXTL+WxQogyTcXNlend2dbl9PwlJsD1UlgF8hem8UBWqlmSnOgcoeknDP+KNRepLdncRn7UYjtgqBxRAEUzyDAZLTAWcLnENujoSIAKsgk2V+A3xBQJZBjOLhLJsLK3E0Q6shPPTNSX/Uqz25kvVGPTqL41Yr6jTis2bHKhTfKpV5ePRDhLohnXYrbp+EQEMJme4gxw913cQnRvCTmqOxZasGjEtEHDUJi97rcXMUh8PDm8OQY1EQ9BjMRGFbKsSRXgauoeDuQconuOUaU0TX7B99qggJ/zPr0QYijjIuGdVjSs+jmSWXQ9tC9BiVsNrdUTv8ydVmFjGI48k+MWpG/0CNCc5sCacZpEDI0bC/G3AO2fAJCRhxd3D4gWnOluL40NlusqPsizU3jaIFzyPdk7gdtVrWZ+qXnqgd758LxVkBocYRFodQpk8n7FC+6CE1Sz2PqKvpXHsjliECO9xR3ZI8eiyfzZyzwXd3qKoFo+iXi1vbafmugD/erH8apXGe/u2zHZZdsF7P5luJV6c4Le6ajVbcaZ6+Q/Piw7PtTi0tdiW6h8M+jZt25VLcTJ6plIV4H4ZTJOoC6ZIGE773S+LcWIxjFEQT+aW/7v4PODEMlYGqaOwo9XH1mt2/o7bH+C07cahF3ty/seLGGJIrOKAPFfGdcbl/cXzUv/hjZ2kPXgHHXZi1l0USM+rKVKmxUfGwl4vuK73kGg7fJhO84xPNzrlMwurzULeWhOWnoW7tD9LEGUo=
qcDPJjgE5L3zKhCZ
